Relationship between patient characteristics and serum etonogestrel concentrations in contraceptive implant users.

08:00 EDT 10th April 2019 | BioPortfolio

Summary of "Relationship between patient characteristics and serum etonogestrel concentrations in contraceptive implant users."

To determine whether serum etonogestrel concentrations in contraceptive implant users are associated with certain individual patient characteristics.


Journal Details

This article was published in the following journal.

Name: Contraception
ISSN: 1879-0518


DeepDyve research library

PubMed Articles [27156 Associated PubMed Articles listed on BioPortfolio]

Influence of Genetic Variants on Steady-State Etonogestrel Concentrations Among Contraceptive Implant Users.

To identify genetic variants that influence steady-state etonogestrel concentrations among contraceptive implant users.

Synthetic progestin etonogestrel negatively affects mating behavior and reproduction in Endler's guppies (Poecilia wingei).

High rates of progestins consumption in the form of active ingredients in women's oral contraceptives and other hormonal preparations may lead to their increased concentrations in aquatic environments...

Assessment of biomarkers in women with endometriosis-associated pain using the ENG contraceptive implant or the 52 mg LNG-IUS: a non-inferiority randomised clinical trial.

The aim of the study was to assess the serum levels of the following biomarkers in women with endometriosis-associated pelvic pain before and after six months of using the etonogestrel (ENG) contracep...

Cluster Randomized Trial of a Patient-Centered Contraceptive Decision Support Tool, My Birth Control.

Research suggests the need for improvement in the patient-centeredness and comprehensiveness of contraceptive counseling. My Birth Control is a tablet-based decision support tool designed to improve w...

Plasma concentrations of etonogestrel in obese women using oral desogestrel before and after Roux-en-Y gastric bypass surgery (RYGB): a pharmacokinetic study.

To investigate whether RYGB affects oral desogestrel (etonogestrel) pharmacokinetics.

Clinical Trials [10170 Associated Clinical Trials listed on BioPortfolio]

Pharmacogenomics of Contraception: Genetic Variants and Etonogestrel Pharmacokinetics

The proposed study will investigate the relationship between genetic variants and serum contraceptive hormone levels, specifically the progestin etonogestrel. This study will provide the f...

The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users

A prospective, non-inferiority study to evaluate the pharmacokinetic effect of topiramate on serum Etonogestrel (ENG) levels in contraceptive implant users.

The Effect of Isotretinoin on the Etonogestrel Contraceptive Implant

This exploratory study will fill a knowledge gap regarding the pharmacokinetic effects of isotretinoin on the etonogestrel (ENG) contraceptive implant.

A Study to Investigate the Contraceptive Efficacy and Safety of a Subdermal Etonogestrel Implant (Implanon®)(P06473)(COMPLETED)

The primary purpose of this study is to investigate the contraceptive efficacy, safety and acceptability of Organon's subdermal etonogestrel implant in healthy female volunteers in various...

Comparison of Serum Contraceptive Hormone Levels Between Normal Weight and Obese Users of the NuvaRing®

There are over 60 million women of reproductive age in the U.S. and a majority of these women qualify as overweight or obese. Evidence suggests that there is an association between increa...

Medical and Biotech [MESH] Definitions

The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups.

The rate of success or failure of a method of CONTRACEPTION; CONTRACEPTIVE AGENTS; or CONTRACEPTIVE DEVICES.

Surveys that measure the usage rate of CONTRACEPTIVE DEVICES or CONTRACEPTIVE AGENTS.

An ACUTE PHASE REACTION protein present in low concentrations in normal sera, but found at higher concentrations in sera of older persons and in patients with AMYLOIDOSIS. It is the circulating precusor of amyloid A protein, which is found deposited in AA type AMYLOID FIBRILS.

An indicator and reagent. It has been used for several purposes including the determination of serum albumin concentrations

Quick Search


DeepDyve research library

Searches Linking to this Article